Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 7NIH 5NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Squamous Cell Carcinoma of Head and Neck 41Head and Neck Neoplasms 41Uterine Cervical Neoplasms 31Lung Neoplasms 28Carcinoma, Non-Small-Cell Lung 23Ovarian Neoplasms 16Urinary Bladder Neoplasms 14Stomach Neoplasms 12Carcinoma, Ovarian Epithelial 12Sarcoma 9Neuroblastoma 9Esophageal Neoplasms 9Fallopian Tube Neoplasms 8Medulloblastoma 7Endometrial Neoplasms 7Biliary Tract Neoplasms 7Adenocarcinoma of Lung 7Adenocarcinoma Of Esophagus 7Teratoma 6Central Nervous System Neoplasms 6Brain Neoplasms 6Radiation Injuries 5Neoplasm Metastasis 5Lymphoma, Large B-Cell, Diffuse 5Lymphoma 5Esophageal Squamous Cell Carcinoma 5Brenner Tumor 5Anus Neoplasms 5Urethral Neoplasms 4Testicular Neoplasms 4

Interventions

Vincristine 18Cyclophosphamide 18Cytarabine 17Methotrexate 15Doxorubicin 15Prednisone 11Etoposide 11merphos 10Radiotherapy 10Dexamethasone 9Rituximab 8Leucovorin 8Calcium Dobesilate 8pegaspargase 7Filgrastim 7Daunorubicin 7dexamethasone acetate 6dexamethasone 21-phosphate 6calaspargase pegol 6azathiopurine 6auricularum 6Thioguanine 6Methylprednisolone 6Mercaptopurine 6Asparaginase 6Specimen Handling 5Hydrocortisone 5Granulocyte Colony-Stimulating Factor 5prednylidene 4deltacortene 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Burkitt Lymphoma × Cisplatin × Clear all
NCT00078949 2023-08-23

Chemotherapy Before Autologous Stem Cell Transplantation +/- Rituximab in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma

Canadian Cancer Trials Group

Phase 3 Completed
849 enrolled 13 charts
Lymphoid

Burkitt Lymphoma, Immunoblastic Lymphadenopathy, Lymphoma, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic

NCT00310128 2016-02-03

Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma

AIDS Malignancy Consortium

Phase 2 Withdrawn
Lymphoid

Burkitt Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, AIDS-Related, Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡